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Abstract
Background: Loss to follow-up (attrition) is a frequent problem in clinical trials and can introduce bias or reduce
power. So, understanding retention issues and strategies to address these are important. As part of a multi-method
project, this qualitative study aimed to explore retention strategies used by trial teams and factors which may
influence strategy adoption.
Method: A purposive sample of active trials was selected from the UK NIHR HTA portfolio of ongoing trials in 2014/
2015. Semi-structured interviews with several trial team members from each trial and supplementary interviews
with experienced trial managers explored strategies in collecting clinical outcome data and retaining participants.
Interview data were analysed thematically using techniques of constant comparison.
Results: Twenty-two semi-structured interviews with trial team members including chief investigators, trial managers,
nurses and research administrators revealed strategies used to enhance retention. Some were recognised methods and
planned from trial outset whilst others were implemented more responsively. Interviewees placed great value on
fostering positive relationships with trial participants to enhance retention. However, these strategies took time which
was not always appreciated by the wider trial team or funding bodies. The national focus on recruitment targets in
networks posed a challenge to staff and was deemed detrimental to retention. The ‘moral compass’ of individual
researchers relied on their own beliefs and values and research experience and the factors affected their confidence to
pursue participant data during follow-up.
Conclusion: The role of trial staff and their underlying behaviours influence retention practices and, combined with
emphasis on recruitment targets, can be detrimental to motivation and retention activities. There is a need to consider
how to train and support trial staff involved in retention practices and recognition of retention from funding bodies
and oversight organisations.
Keywords: Retention, Qualitative study, Randomised trials, Incentives, Research nurses, Moral compass
Background
One of the most frequent problems in clinical trials is
the failure to attain completed outcome data for all re-
cruited participants [1]. Loss to follow-up (attrition), is
problematic as it can compromise study validity and lead
to research waste [2]. Reduced overall sample size affects
the power and effect size of the trial and bias can be in-
troduced [3]. For instance, if characteristics or numbers
of patients who drop out differ across arms, this can
affect intention-to-treat analysis [4–6].
Much attention has been given to recruitment-
enhancing strategies including identification and under-
standing of successful approaches [7]. Insight into the
factors which influence decisions and behaviour under-
pinning these strategies has also been reported [8]. The
extensive work on recruitment into trials may be rele-
vant to other aspects of trial conduct. For example, in a
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synthesis of qualitative data extracted from six rando-
mised controlled trials (RCTs), it was found that recruit-
ment was a complex and fragile process [9]. Research
nurses used their discretion over whom to inform about
the RCT and to approach for recruitment, based on what
they believed within their clinical or advocacy role and
sometimes pre-conceived stereotypical views about
groups or individuals. This research highlighted the vari-
able enactment of a study’s protocol and that opportun-
ities for RCT recruitment could be missed because of
clinicians’, especially research nurses’ views. It was not-
able that many nurses were unaware of making the
judgements or the rationales for doing so [9]. Thus, trial
staff may face challenges managing their dual roles,
faced with what they may experience as competing goals
of encouraging patients to participate in a trial that may
damage clinician-patient relationships [10, 11]. The
above qualitative work and other research into trial re-
cruitment [7, 11–13] indicate that the views, beliefs and
experiences of trial team members are important influ-
ences on trial conduct. However, to date less attention
has been given to understanding how retention strat-
egies are developed and implemented by trial staff.
Brueton and colleagues [14] conducted a systematic
review of 39 randomised studies of retention interven-
tions nested within randomised trials. Findings identified
effective strategies such as monetary incentives, but did
not explore how or why strategies may work, or what
participants consider to be a good incentive. Further-
more, although the eligibility criteria for the review were
wider, the identified studies were also limited in that
they assessed postal or electronic questionnaire response
rates [15, 16]. The lack of research into retention was
further highlighted by a recent survey about the
methods and practices routinely used by UK clinical tri-
als units (CTUs) to improve retention, conducted by
Bower and colleagues [17]. Their survey response rate
was low (38%) but their results provided examples of
formal strategies used by CTUs to encourage retention
such as, planning additional contacts with participants
(reminders, newsletters and websites), providing flexible
appointments, reducing research burden, incentives and
building relationships between researchers and partici-
pants through Christmas and birthday cards. The im-
portance of building and maintaining relationships with
patients to enhance retention was highlighted.
While research on retention has identified several po-
tential strategies, there has been little exploration of the
effectiveness of such strategies, how they are used by
trial researchers and how broader influences alter the ef-
fectiveness of such strategies. The ‘Losing the Losses’
study sought to address this gap by exploring reasons
for failure to collect completed outcome datasets in tri-
als. As part of a multi-method study, this qualitative
component aimed to elicit how trial teams seek to retain
trial participants and reasons for using retention strat-
egies and factors which may influence their retention be-
haviours, to generate recommendations for retention
enhancing strategies for trial teams.
Methods
A cross-sectional qualitative study was conducted using
semi-structured interviews to elicit detailed accounts
from trial team members about: their current practices
to maximise retention within their respective trials, rea-
sons why these practices were employed and factors per-
ceived to impact use of retention strategies.
Sample and recruitment
Sampling was a two-stage process. Firstly, a purposive
sample of active trials was identified from the UK
National Institute for Health Research, Health Technology
Assessment (NIHR HTA) portfolio of ongoing trials dur-
ing 2014 (80 trials) by AK. Identification of trials involved
searching the major UK funding body website and listed
protocols. Sixteen trials were initially identified by AD and
AS as appropriate to be approached for inclusion in the
study based on an agreed sampling framework. Trials
were sampled to include a range of the following: clinical
topics, primary or secondary care settings, trial outcomes,
length of follow-up period and procedure for collecting
the trial outcome. The identified trials were discussed with
the Losing the Losses study team and consensus was
reached to send invitation to all to participate in qualita-
tive study. Invitations were sent by letter to the trial chief
investigators (CIs). Following expressions of interest from
this sample of 16 trials, we sought to identify in the
region of five trials to act as exemplar cases with a
range of trial characteristics including reported
retention success, clinical topics, healthcare settings
(primary or secondary care) and complexity of inter-
ventions. We aimed to reach a sample of five trials
which was deemed to be sufficient to address the re-
search aim and provide enough information on reten-
tion strategies, reasons for use, and factors impacting
use, across several trial types [18]. We expected to in-
clude the first five trials to agree. Secondly, within
the selected ‘case study’ trials, team members were
purposively sampled, using researchers’ knowledge of
the trials and roles of team members within selected
trials to gain a range of views on retention strategies
from those having different roles within the teams.
Selected members were either approached by their tri-
al’s CI or directly by the study researcher (AD) and were
invited for interview with a study information sheet which
set out the aims and goals of the study. Individual written
consent was given by all interviewees.
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Data collection
All interviews were conducted by AD, a skilled inter-
viewer and experienced qualitative researcher in health
research. Interviewees were not known to the study
team prior to interview. Interviews were guided by a
semi-structured interview schedule which allowed inter-
viewees to expand on responses to questions and raise
issues of importance from their perspective [19]. The
interview topic guide covered: interviewees understand-
ing of retention; perceptions and experiences of reten-
tion issues within the current trial, as well as strategies
to enhance retention, both within the current trial and
in other trials they had been involved in previously.
Reasons for the use of retention strategies and factors
impacting use were explored. Participants were also
asked about future strategies and promising retention in-
terventions that they would use or recommend to other
trials. Interviews were carried out face-to-face or by tele-
phone except for one participant who participated via
email (this email response was concise, offering little
elaboration on the questions sent). Interviews lasted be-
tween 45 and 90 min. The first part of the interview was
spent developing rapport before starting questioning.
Interviews were audio-recorded and transcribed verba-
tim for analysis purposes. Interviews were conducted be-
tween April 2014 and January 2015.
Data analysis and rigour
Transcripts were analysed using thematic analysis [20]
and methods of constant comparison [21]. Preliminary
analysis was conducted by the primary researcher (AD)
alongside data collection to enable early data to inform
subsequent data collection. Areas of interest were
flagged and pursued in more detail in subsequent inter-
views. Through a combination of deductive line-by-line
coding based on the study aims and inductive analysis
allowing for more emergent codes, an initial coding
framework was developed and discussed in detail with
other researchers on the team (AS, AL, AK and CG).
Preliminary coding of a subset of interviews was con-
ducted by AS, which further refined the earlier coding
framework. Discrepancies in coding were identified and
discussed within the research team for this study and
agreement to adapt coding and restructure themes was
reached. The main analysis occurred once data collec-
tion was complete using the qualitative data manage-
ment software NVivo 10 (undertaken by AD and CC)
[22]. Codes were grouped and refined into broader cat-
egories and higher-level recurring themes. Data were
compared within and across interviews from all repre-
sented trials, according to interviewee role and trial
characteristics, e.g. clinical topic. Data within themes
were scrutinised for disconfirming and confirming per-
spectives. The analysts monitored the process until
information power (sufficient range and quality of infor-
mation provided by interviews to address research ques-
tion) and data saturation (no new information or themes
being revealed) was achieved [18, 23].
Ethics, consent and permissions
The study was approved by the University of Bristol Faculty
of Medicine and Dentistry Research Ethics Committee
(13145 (10681)). All participants gave informed consent
and agreed to anonymised quotes being used in
publications. In presenting findings, data have been anon-
ymised to protect confidentiality. Quotes are presented by
case and role of interviewee, e.g. C4_TM (Case 4_Trial
manager) or SI_STM1 (Supplementary interview_Senior
trial manager 1).
Results
Sixteen trials were invited to participate. Seven trials did
not reply, one declined and two excluded themselves
from the study as they felt that they had less relevant
data to contribute than other trials. Of the remaining six
who agreed to take part, one was unable to participate
within the qualitative study timeframe and was, there-
fore, excluded. Within the five participating trials, 20
trial team members were approached for interview, one
of whom did not respond to initial contact. Therefore,
19 trial team members from across the five trials were
interviewed including, chief investigators (CIs) (x 4), trial
managers (TMs) (x 5), research associates (RAs) (x 3),
research fellows (RFs) (x 2) a trial administrator (TA) (x
1) and research nurses (RNs) (x 4). A further three se-
nior trial managers (STM) who were not part of the five
trial cases were approached and agreed to take part in
supplementary interviews bringing the total number of
interviews to 22. Senior trial managers were identified
through existing team networks and recommendations
from case trial teams. Twelve interviews were conducted
over telephone, six were face-to-face and one was done
via email. Table 1 shows the characteristics of the five
trials and interviewees. Data saturation was achieved
during completion of collection and analysis of the 22
interviews as agreed by the study team.
Analysis revealed that while it was important to ac-
knowledge the role of participants in committing to the
trial and providing follow-up data; it was the behaviours
of the trial team which further influenced retention.
Recognised and unrecognised influences on retention
are described in detail below. Recognised influences on
retention were more likely to be acknowledged by teams
and included (1) planned and unplanned or responsive
study protocol strategies, (2) the importance of building
and maintaining positive relationships with trial partici-
pants and (3) the tension caused by national oversight
bodies, such as funders and research networks or, ‘the
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system’, placing more focus on recruitment rather
than retention, to the detriment of retention. Unrec-
ognised influences which were less overt and became
more apparent to interviewees as they discussed re-
tention and included (1) the ‘moral compass’ of indi-
vidual trial team members, (2) interviewee’s level of
trial experience and (3) the influence on researcher
behaviour of being able to give incentives to
participants.
Recognised factors and influences on retention
Planned and unplanned trial processes and conduct
Interviewees identified a range of practical activities re-
lated to trial conduct which they felt could enhance re-
tention. Most were trial process strategies and had been
planned and built into the trial protocols and Standard
Operating Procedures (SOPs) at the design stage and
were regarded as good practice. However, some strat-
egies were unplanned and responsive, in reaction to re-
tention issues that emerged during the trial. Examples of
planned trial conduct strategies to enhance retention in-
cluded: clear and transparent data collection procedures;
decreased outcome measure burden; explanation of what
participation in the trial involved when seeking partici-
pants consent; presentational and communication strat-
egies such as branding, logos, professionally printed
questionnaires and trial newsletters for participants;
nomination of best contact for participants and persona-
lised participant follow-up such as a nominated trial ad-
ministrator for each participant or family. Interviewees
referred to these planned strategies as ‘formal’ strategies
– perhaps because they were officially sanctioned or
recognised within study protocols and SOPs:
‘I think the formal things are a strategy of contact. If
we don’t get hold of them, sending them a letter,
making sure that we have got the right phone
numbers for them. Those are all formal things that
we’d put in place, to make sure that we have the
opportunity to get hold of parents and retain them.’
(SI_STM3)
‘We send newsletters out … I send thank-you cards
after every visit.’ (C4_RA)
However, the benefits of being responsive on a case-
by-case basis was also emphasised by interviewees and
required a degree of flexibility with planned strategies if
retention rates were low. This required staff to have the
skills to think both laterally and creatively in response to
ongoing retention rates:
‘It’s looking at what’s actually happening with the
strategies that you’re using and just thinking laterally
about what could be done to change that, or how you
could implement something that maybe would
improve it, and that’s what I think doesn’t happen
often enough.’ (SI_STM2)
In addition to formal strategies, the interviewees also
used a range of informal strategies that were not always
documented in the trial paperwork. These strategies
Table 1 Characteristics of trials and interviewees
Trial Clinical topic Primary or secondary
care
Trial outcome Follow-up
period
How trial outcome collected Interviewees
1 Obesity Primary Change in Body Mass
Index (BMI) z-scores
12 months Home visit Chief investigator
2 x research fellow
trial administrator
n = 4
2 Renal Secondary Physical function 12 months Clinic visit Chief investigator
3 x research nurse
senior trial manager
trial manager
n = 6
3 Depression and
cancer
Primary and
secondary
Clinical depression
score
24 weeks Home/clinic visit or
telephone contact
2 x research
associates
research nurse
trial manager
n = 4a
4 Fall prevention Primary and
secondary
Rate of falls 12 months Postal by monthly falls
calendars
Chief investigator
research associate
trial manager
n = 3
5 Dementia Primary Goal setting interview 9 months Home visit Chief investigator
trial manager
n = 2
aCI did not respond to invitation
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were more likely to be responsive, developed in reaction
to issues that arose during the conduct of the trial and
might be ‘upgraded’ to documented strategies if they
proved useful as the trial progressed:
‘So, if the informal ones become useful, you can
add it in as a new strategy and ask it of everyone.’
(SI_ STM2)
Whilst the interviewees could provide anecdotal sug-
gestions of strategies they felt were useful for enhancing
retention based on their prior experiences, they were
aware of the lack of evidence in support of retention
strategies. They gave examples of thinking about nested
methodological studies within trials to obtain this
evidence, such as a ‘comparison of incentives versus no
incentives’ (C2_CI), but the majority had not been able
to carry this forward due to lack of funding and re-
sources as well as not having the methodological expert-
ise available within the trial team to conduct such
studies. However, in the view of one chief investigator,
not performing nested studies was ‘a wasted opportunity’
(C5_CI) to enhance both the evidence base and the cur-
ricula vitae (CVs) of research staff by publishing papers
on these nested studies.
Trial participant and team members’ interrelationships
Trial staff who interacted with participants placed
great value on maintaining contact with participants
and interpersonal relationships to enhance retention.
Those relationships were forged using informal rela-
tional strategies; for example, by making cups of tea
during trial appointments, by offering flexible ap-
pointments to suit the participants’ needs and arran-
ging free car parking. Interviewees would also follow
up participants with telephone calls if participants
became ill during the trial even if the participants’
illness had nothing to do with the trial:
‘I think building a good relationship with the
participant when you first meet them is very
important because I think that if you’ve got a good
relationship they’re more likely to stay in the study.’
(C3_TM)
However, these social relational actions required add-
itional time which the interviewees felt was not always
valued by the wider trial team and not routinely ac-
knowledged within the funding of trials:
‘That needs to be reflected in the amount of funding
that is required for research nurse time. You cannot
do trials on older people where they drive up to the
front desk of your clinical research centre. They nip
in, you spend half an hour with them and then they
bugger off again, it doesn’t work like that… I think
those are important things that need to be factored in
and I don’t think that some of the funding bodies get
that.’ (C2_CI)
National focus on recruitment rather than retention
Identified as a challenge to retention in trials, interviewees
felt that ‘the system’ (C1_CI, C2_CI) including funders and
research networks placed too much emphasis on recruit-
ment targets and insufficient attention to retention. Trial
performance was often assessed on recruitment rates
by monthly targets. Interviewees felt pressurised by
funders to focus on recruitment, particularly at the
start of the trial, for fear of the trial funding being
withdrawn and the trial being stopped. Consequently,
there was little focus on retention strategies at trial
outset so these strategies had to be developed and
implemented subsequently:
‘I do worry about that. That’s always been the case
that the networks, the portfolio, all of the attention is
recruit, recruit, and that’s what the financial incentives
are, for the (recruitment).’ (SI_STM1)
‘We really struggle to meet the targets and there have
been questions as to whether the trial would stay
open and things like that. So, if you know the
funding’s not going to be there, then you just focus on
recruiting. I think especially at the beginning of this
study, we had such a focus on recruitment, I think it
was only probably 6 months in when recruitment
started to kind of stabilise a bit that we thought, “Oh,
God. What about retaining people? What’s our
follow-up like?” We didn’t even think about it until
that point.’ (C3_RA2)
Interviewees wanted an equal emphasis on recruitment
and retention with a greater acknowledgment of the value
of both for the scientific integrity of trials:
‘Obviously, it’s really important to keep the
participants in the trial. I see the business model in
here because the work and effort that goes into
recruiting the patient, and that’s where all the metrics
are: how many recruited? … For me, the effort that
goes in has to be equal if not more to retain that
participant in the trial. … Retention for me is really
important, the recruitment is really important but
retention definitely more so because of the effort that
gets that first patient in and continue for the trial … if
you don’t have the retention, you’ve got a scientific
integrity issue’. (C2_STM)
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The current focus of National Clinical Networks on
recruitment was felt to be demotivating and some more
senior trial team members allocated service support
costs to aid successful retention:
‘For the portfolio, nobody’s interested in retention;
they’re just interested in recruitment, but I have used
the service support costs to ensure retention. So, I’ve
split the service support costs so you get a certain
amount for recruitment, then you get a certain
amount for follow-up, or whatever; if they’re doing
your notes reviews. It’s exactly like you’d pay a
builder; “You do the work, then you’ll get paid. If
you don’t do the work, you’re not getting paid.” …
And I think that’s why, as well, we managed to get
100% (retention).’ (SI_STM3)
Incentives to enhance retention
There was some support for incentives targeted at trial
participants for follow-up but the risk of coercion was
raised:
‘I suppose you have just got to be careful about
unintended consequences. Because if you are paying
people to do that then there is a danger that you end
up with people, not quite being coerced to stay in
studies, but that is a potential problem.’ (C2_CI)
In addition, difficulties of using retention as a trial per-
formance metric were raised with concerns that this
could impact willingness of sites to take on studies with
known retention challenges:
‘But also, you might get a problem that people are
reluctant to become recruiting centres as there might
be a significant drop out … So, if you were doing a
trial with a long follow-up or you are doing a trial
with a bunch of old frail people, or you are doing trials
where it isn’t death and hospitalisation outcomes then
you might find that people are less likely to want to
become recruiting centres for those trials if you are
incentivising them on retention rather than on
recruitment.’ (C2_CI)
Unrecognised influences on retention
Unrecognised influences were at first not explicitly artic-
ulated during interviews and appeared less overt to in-
terviewees than those already discussed. As participants
talked about retention, some of the more implicit and
‘unconscious’ strategies emerged and were recognised by
participants during interviews, even if not thought about
or acknowledged explicitly before.
The moral compass of individual trial team members
Interviewees seemed unaware at first of how their own
‘moral compass’ influenced retention of participants.
They expressed how they often used their own beliefs
and values regarding how to interact with participants,
reflecting for example on how they would want their
own parents to be treated, or projecting their own feel-
ings onto a situation. At times, prioritising participants’
(projected) feelings may conflict with the pursuit of
follow-up data:
‘I always say “if this was a researcher talking to my
mum would I be comfortable with what they were
saying?” That is my starting point, would I be happy
that someone was saying this to her? If I think I
wouldn’t be that happy with someone saying that then
I know for me that is not right… It is your own
personal value and how you would want to be treated
or your family treated.’ (C5_TM)
‘I suppose it is the kind of person I am. I don’t want
to hassle someone who has already got an advanced
cancer and depression, I don’t feel that is right. I
suppose they are my thoughts impacting on the
retention I suppose.’ (C3_RA1)
Interviewees believed that the care of the participant is
paramount and that coercion is unacceptable. Trial staff
appeared to prioritise participants’ ‘rights’ and the ethics
of their interactions with participants, which aligns with
Good Clinical Practice (GCP). However, in the context of
retention, their own ethics or ‘moral’ stance on acceptable
pursuit of participants may clash with the goals of scien-
tific rigour. Interviewees projected their own feelings of
what is acceptable ‘chasing’ of participants and how this
can be at odds with the study management’s desire for
complete data collection:
‘I would be horrified to think I had coerced someone,
however gentle that may be, into doing something
they really didn’t want to do.’ (C2_RN2)
‘I guess in the cases like I was saying when, for instance,
I was arranging the follow-ups with somebody, I knew
that they didn’t want to complete this but I was told to
keep going. In the other case where the woman was
hanging up (the phone) on me, I knew she didn’t want
me but I was told to keep going. So yes, this does
happen … But the senior trial team very often just
don’t understand the level of burden that the entire
set of outcome measures are putting on somebody.
So, that can be awkward I think … It’s hard to
understand I think sometimes, the level of
impairment that you’re facing with some people in
Daykin et al. Trials  (2018) 19:76 Page 6 of 11
terms of the length of time it’s taking and how dif-
ficult they’re finding it.’ (C3_TM)
Interviewees (usually study researchers or research
nurses) with direct participant contact were continu-
ously in conflict with the chief/principal investigator
who was unaware of the potential impact of striving for
complete data collection on participants:
‘I don’t know. I think maybe my boss has said like,
“You should definitely try and follow them up. You
should…” He’s keen to always capture data and he’ll
say like, “You should go to the hospital bed and go
and follow them up.” He’s kind of a bit more
comfortable to push for the data a bit further, whereas
I’m – maybe I’m less confident than he is. But if I feel
like it might be upsetting for someone, I’ll be more
likely to say, “Oh, no, it’s fine. Don’t worry. We’ll leave
it there.” So I think it’s just a personal – what you feel
comfortable with. Maybe I’m a bit oversensitive with
that but… And I think maybe because I’ve met the
patient; I’ve done their baselines; I’ve got to know
them quite well. Maybe I’m just a bit more
understanding of what’s going on. Whereas my boss
wouldn’t have met them and he’ll just be like – he’ll
just see the data, kind of thing.’ (C3_RA2)
‘I’ve spoken to (the CI) about this, and she’s – I don’t
know. Maybe because she’s not actually the one doing
the calls, she’s all for, “Just keep going, keep going,
keep going.” I’m thinking, “Actually, to me, ethically,
there comes a point…” Usually, for me, it’s after about
three or four voicemails or emails. For me, that’s
enough. I will not do more than that. It doesn’t feel
ethically right, for me.’ (CS1_TA)
Challenges were identified for interviewees who were
clinicians (e.g. counsellors or nurses), who especially felt
tensions between their role of clinician and patient advo-
cate, and trial researcher in pursuit of data. Sometimes
the dual role of clinician and researcher was comple-
mentary whilst, at other times they experienced internal
friction between these roles. At times, this left the clin-
ical researchers feeling uncomfortable and demotivated
to pursue data from participants:
‘Yes, it’s difficult, isn’t it? I guess that’s where I
struggle, actually, because me for my way of being
wouldn’t do it, but me with my trial administrator hat
on says, “You’ve got to do it. We need that data.”
There’s a bit of an internal wrestle with that, as well,
really. Yes. Maybe I shouldn’t worry about it; just be
hard-nosed and ring them up. Hmm; I’ll have to think
about that one (laughter). … I guess that’s a
hindrance, my background, actually, because I prob-
ably make assumptions about families, whereas if I
hadn’t got my counselling training, I’d be thinking,
“No; get the data, get the data.” Maybe. … To me, I
thought, “I’ve got to look at the whole picture.” Yes,
put like that: don’t have a counsellor being a trial
administrator. It doesn’t work, really, because I think,
“Well, you’re going through enough at the moment.
You don’t want me saying ‘but can I…? Can I…? Can
I…?’” No; it feels inappropriate.’ (C1_TA)
‘They said that they felt that usually, their role as a
nurse is always to give and to care, and when they're a
research nurse, they’re taking, and they’re not used to,
or comfortable in doing that.’ (SI_STM3)
Experience of trial team members
The influence of the level of trial experience of team
members on retention practices also appeared unrecog-
nised; for example, in participant withdrawals from the
trial and the extent to which they would pursue further
data collection from trial participants. More experienced
interviewees emphasised different levels of withdrawal
and even used different terminology such as ‘change in
status’ (SI_STM1) or ‘opt-out of continuing’ (SI_STM2):
‘I mean for me, if it’s me sitting in that position and I
know I shouldn’t do that or one of my family
members sitting there… if I say, “really from a tablet
perspective, I don’t want to take any more, to me
that’s enough”. I wouldn’t want to be badgered into it
anymore. So, I suppose it is from a personal
perspective isn’t it?’ (C2_RN2)
They felt it was ‘crucial’ (SI_STM2) to be flexible and
were happy to negotiate with participants to at least
collect primary outcome data:
‘We try very hard to make the distinction especially if
it is an intervention patient, if it was withdraw from
treatment or withdraw from the trial totally. What
happens is often people will want to stop doing the
exercises or stop wearing the insoles but they are very
happy to provide us with information and fill in the
questionnaires. We make this real distinction between
withdrawing from treatment and withdrawing from
the study. That is one option we normally talk to
people about.’ (C5_TM)
Interviewees with less experience reported having less
confidence to pursue participants for outcome measure
data, as they assumed the participants wanted to with-
draw from all aspects of the trial and made no further
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contact with them. Less experienced interviewees sought
advice from those they deemed more experienced and
adopted their advice. Interviewees also reflected on how
they learnt key retention strategies ‘on the job’:
‘Yes. I think it’s definitely experience. I’d say mainly,
it’s experience. Because even in the last year, I’ve got
more confident about asking people and just kind of
testing my beliefs or whatever. I’ve tested whether I
could push for that data and ask people to do a little
bit more and the end result has been okay; like no
one’s really minded. So that’s made me confident …
But also, like I said, we’ve had supervision and just
speaking to someone who is really experienced and
who at the same time, I think is a really a
understanding – she’s a really experienced research
nurse who I’ve got a lot of respect for and I know
she’s really good with patients. Just hearing her say,
“You can kind of ask if you can go to their house
when they’re unwell. Or you can ask if you can do
‘this’”. Just hearing it come from her kind of made me
try and get the data a bit more.’ (C3_RA2)
Unconscious influence of incentives
Interviewees recognised that incentives influenced reten-
tion as discussed earlier but seemed unaware that incen-
tives may also affect their own behaviour or at least their
perception of their behaviour and how they felt about
their role. Incentives appeared to empower interviewees
to feel more confident and comfortable maintaining
contact with participants over time and more motivated
to pursue acquisition of data from participants. They be-
lieved that being able to provide incentives provided
them with more appeal in their interactions with
participants:
‘In the (name) study, the nurses requested that it
would be nice to give the children something for
having taken part in the trial. They raised it with me
… for the nurses, it was something nice that – they
felt more comfortable then, asking for the data, if they
knew that the child was going to get a little gift at the
end … and I do feel that it gave the nurses a
legitimate reason, in their mind, to press on with
collecting the data, because they knew that the parent
or the child was going to get something at the end. So
if it helped them to do their job and collect the data
that we needed, then it was good … the nurses were
very pleased that I’d listened to them, brought it to
the management group. The academics were like, a
bit of a waste of money at first, and I said, “Look, I
think the nurses really would like to do this, and
we’ve got the money. It’s not going to do any harm.”
And it was only subsequently that I came to the
conclusion that actually, it’s made them realise that
they feel more confident in asking, because they know
that they’re going to give them something at the end.’
(SI_ STM3)
Discussion
Interviewees in a qualitative study of five active rando-
mised trials in the UK revealed strategies deployed by
trial researchers to enhance retention. Some were
methods that were well recognised, and others were new
methods that had been previously unrecognised but
were proactive and responsive. Key findings were the
importance of building relationships between trial staff
involved in retention work and the trial participants, the
role of researchers’ beliefs about their responsibilities
and professional values and emphasis given to recruit-
ment means that retention is often eclipsed. Revealed
within interviewees’ accounts was the influence and
impact of such factors not only on trial participant
behaviour but also on the views and behaviours of trial
team members. This work has highlighted the import-
ance of recognising the role of trial staff within retention
practices and how current emphasis on recruitment
targets can be detrimental to motivation and retention ac-
tivities. There is a need to do more work to understand
and consider how to support staff involved in retention
practices through training, support and additional re-
sources from the wider trial team, funding bodies and
oversight organisations.
One key recognised retention strategy was incen-
tives, either gifts or monetary. Evidence suggests that
monetary incentives increase postal and electronic
questionnaire response [14] possibly because they lead
to more effort and higher performance from the re-
cipient [15, 16]. Our data suggests that incentives
may additionally affect the trial team member behav-
iour in that they feel more confident and comfortable
maintaining contact with participants and more moti-
vated to pursue the acquisition of data. This finding
interestingly shows how qualitative data from inter-
views can support and further illuminate data from
questionnaires. In addition, presenting incentives
helped trial staff to feel that they had more appeal in
their interactions with participants. Our study, there-
fore, supports the proposal that the incentives within
trials should be prioritised in the funding of further
methodological research to improve recruitment and
retention [17] and to explore additionally why they
may be effective.
Our qualitative data suggests that the trial researchers’
moral compass could compliment, but occasionally be at
odds with, the overall study aim for complete data
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collection. There are examples of researcher’s views and
beliefs affecting recruitment [11] and we identified how
interviewees reflect on how they would like themselves
or their own parents to be treated as a barometer of
acceptable moral research practice. This ‘moral compass’
needs to be acknowledged and understood more by trial
teams, with greater appreciation that those in direct
contact relationships with participants may experience
difficulties in dealing with recruitment pressures from
trial oversight and management groups. It also needs to
be noted that even when the study being conducted is a
randomised trial, where bias and subjective factors
which may influence differences in outcomes between
the arms are reduced, personal, subjective factors still
play a role in retention. These factors if not accounted
for can directly affect outcomes and validity of the trial.
Additionally, as shown in studies in recruitment [8, 9],
trial researchers who are also clinicians may need
additional support from clinical as well as research col-
leagues to help them manage their complex dual roles.
This study showed that those with less trial experience
struggled with pursuing trial data. Due to lack of experi-
ence they may be unable to use discretionary judgement
and will use standard procedures to guide their task
performance [21]. Support for novice researchers or
those new to the clinical/researcher role may require
additional support from more experienced team mem-
bers. By making explicit in trial protocols the lengths
that are considered acceptable to collect follow-up data
as well as explicit distinctions between discontinuing
treatment and discontinuing follow-up can be helpful to
those on the ground. Stating specific stop criteria and
supporting novice researchers would also contribute to
less research waste and increasing the value gleaned
from trials [2]. It may also be beneficial for trial staff to
engage in a form of reflexive practice, whereby individ-
uals engage with challenging personal beliefs and as-
sumptions to improve professional and personal practice
[24]. Such practices may be beneficial to recognise one’s
own moral compass and the effect that this may be hav-
ing on retention practice and should be explored within
training of those working in clinical trials.
This study has highlighted that strategies tended to be
implemented without an appropriate evidence base to
support their effectiveness but were based on prior experi-
ence or anecdotal accounts were accepted. Embedded
methodological studies were welcomed in terms of the
evidence that they could provide as well as boost staff de-
velopment but, due to a lack of time, money and resources
it was not always possible to conduct such studies. There
was also a lack of methodological expertise available
within the trial teams to design and carry out methodo-
logical studies. Studies Within a Trial (SWAT) are becom-
ing more common [25]; however, providing a robust
evidence base for retention in trials through nested meth-
odological studies needs to be explored further. For such
studies to become routine, further recognition of their
value, additional resources and more methodology re-
searchers are needed.
This study has been conducted in the UK, a high-
income [26] and well-resourced country but the findings
may also translate to trial conduct in other less affluent
countries. Social relationships between researchers and
trial participants have been identified as a key factor in
initial and continued trial engagement in lower- and
middle-income (LMIC) countries [27]. Participant’s
perceptions of a trial are influenced by interpersonal
interactions and relationships with trial staff. Those with
more positive encounters and social relationships are
more likely to view the trial more positively and take
part. However, concerns have been expressed that social
relationships between those conducting and participat-
ing in research can be taken advantage of and reports
have been made of how such relationships have been
used to influence coercion of trial participants [28]. This
can lead to unethical practice and place researchers in
an uncomfortable position which, as this study found,
can adversely affect retention. Motivation to take part
and continue in the trial has also been shown to be
influenced by appropriate remuneration and incentives
in LMICs. Therefore, our findings are helpful when con-
sidering the design and conduct of trials outside of the
UK and in less affluent countries.
Strengths and limitations
This qualitative study has examined the retention prac-
tices of five trials with 22 interviewees which has
captured the complexity and context of staff beliefs and
resulting behaviours when pursuing follow-up data from
patients in trials. Findings are based on first-hand
accounts of those responsible for the day-to-day running
of trials and their retention practices. Interviews allowed
participants to flexibly explore their views, opinions and
experiences which revealed ‘hidden’ influences and
meanings integral to retention behaviours.
However, the five trials in our study are not represen-
tative of all randomised trials and were funded by one
UK funding body. Trials funded through other sources
may face different retention issues and pressures,
particularly those who place differing emphasis on re-
cruitment and retention, but it is likely that results are
transferable across any funder. Since our study was
cross-sectional we were unable to ascertain whether, and
how, the retention challenges were later resolved by the
trial teams and follow-up work involving observation of
trial researchers’ behaviours would be of benefit. It is
also possible that trials which are conducted in different
health/disease areas may face different retention issues
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than those captured within this study. For example, tele-
monitoring in diabetes or chronic heart disease whereby
data are automatically collected, and which may require
less face-to-face contact, may benefit from increased hu-
man interactions to retain interest in the study.
There has been much discussion about the benefits and
limitations of different modes of interviewing including face-
to-face, telephone interviews and email [29]. Limitations of
telephone interviews include less opportunity to build rap-
port resulting in less dynamic conversation. The interviewer
for this study was an experienced interviewer and spent time
at the beginning of the interviews in general conversation
with interviewees which built rapport. This would have ne-
gated some of the limitations attributed to telephone inter-
views. As reported, the one email interview was limited in its
detail. However, in comparison to the volume and depth of
other interview data provided to address the research ques-
tion, this limitation is considered minor.
Conclusion
Strategies deployed by trial researchers to enhance re-
tention included recognised and unrecognised methods.
These factors are underpinned by relationships with trial
participants as well as researchers’ beliefs about their re-
sponsibilities and professional values and led to planned
and unplanned retention practices. However, overall the
pursuit of high rates of retention is constrained by an
institutional emphasis on recruitment. Recognised and
unrecognised retention practices can have implications for
trial outcomes and trial validity and, therefore, need to be
considered when designing future randomised trials.
We therefore recommend that (1) future research
should explore what is perceived to be an incentive as
they are not necessarily expected to be monetary and,
how and why incentives work by including their effect
on researcher behaviour, (2) focus be placed on embed-
ded studies addressing the effectiveness of retention
strategies within RCTs, (3) the balance of organisational
emphasis on recruitment and retention be addressed, (4)
acknowledgement of the moral judgements made by
staff within trials is needed and time for reflection is to
be encouraged and (5) additional support and training
should be provided for researchers/clinicians whilst they
gain trial experience.
Abbreviations
CI: Chief investigator; CTU: Clinical trials unit; CV: Curriculum vitae; GCP: Good
Clinical Practice; NIHR HTA: National Institute for Health Research Health
Technology Assessment; RA: Research associate; RCT: Randomised controlled
trial; RF: Research fellow; RN: Research nurse; SOPs: Standard Operating
Procedures; STM: Senior trial manager; TA: Trial administrator; TM: Trial
manager
Acknowledgements
We thank all the participants in this study. This work was funded by the
Medical Research Council/National Institute for Health Research,
Methodology Research Programme (MR/K024310/1). The views and opinions
expressed therein are those of the authors and do not necessarily reflect
those of the MRC/NIHR MRP. This work was undertaken with the
support of the MRC ConDuCT-II Hub (Collaboration and innovation for
Difficult and Complex randomised controlled Trials in Invasive
procedures – MR/K025643/1).
Funding
This work was funded by the Medical Research Council (MR/K024310/1). The
funding body had no role in the design of the study and collection, analysis
and interpretations of data and in writing the manuscript.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request. Blank informed
consent forms are available on request.
Authors’ contributions
AS, JAL, CG, JB and MC were applicants on the grant that funded this study.
AK was the research associate at the University of Liverpool who conducted
the quantitative element of the research grant and provided access to the
sampling frame. AD was the research associate appointed to this qualitative
study, conducting the interviews and data analysis with the support of AS,
JAL, CG, CC and AK. AD produced the first draft of this manuscript and CC
contributed qualitative expertise and redrafted the manuscript. AD and CC
assimilated collaborators’ comments into subsequent drafts. JB, AK, CG and
MC commented on the final draft of the manuscript. AS was co-principal in-
vestigator with JAL jointly conceived of the study, advised on its conduct,
supported data analysis and developed the first draft of the manuscript to
final draft. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The study was approved by the University of Bristol Faculty of Medicine and
Dentistry Research Ethics Committee (13145 (10681)). Informed consent was
obtained from all participants in the study.
Consent for publication
All participants agreed to their anonymised quotes being used in
publications.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Bristol Medical School, University of Bristol, Bristol, UK. 2Bristol Randomised
Trials Collaboration (BRTC), University of Bristol, Bristol, UK. 3MRC North West
Hub for Trials Methodology Research, Institute of Translational Medicine,
University of Liverpool, Liverpool, UK. 4Collaboration and innovation in
Difficult and Complex randomised controlled Trials In Invasive procedures
(ConDuCT II Hub), University of Bristol, Bristol, UK. 5Queen’s University Belfast,
Belfast, Northern Ireland.
Received: 18 May 2017 Accepted: 20 December 2017
References
1. Akl EA, et al. Potential impact on estimated treatment effects of information
lost to follow-up in randomised controlled trials (LOST-IT): systematic
review. BMJ. 2012;344:e.2809.
2. Ioannidis JPA, et al. Increasing value and reducing waste in research design,
conduct, and analysis. Lancet. 2014;383(9912):166–75.
3. Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions
and the lost and wayward. Lancet. 2002;359(9308):781–5.
4. Dettori JR. Loss to follow-up. Evid Based Spine-Care J. 2011;2(1):7–10.
5. von Allmen RS, et al. Completeness of follow-up determines validity of
study findings: results of a prospective repeated measures cohort study.
PLoS One. 2015;10(10):e0140817.
Daykin et al. Trials  (2018) 19:76 Page 10 of 11
6. Tudur Smith C, et al. The trials methodological research agenda: results
from a priority setting exercise. Trials. 2014;15(1):32.
7. Treweek S, et al. Methods to improve recruitment to randomised
controlled trials: Cochrane systematic review and meta-analysis. BMJ Open.
2013;3(2):e.002360.
8. Lawton J, et al. Recruiting and consenting into a peripartum trial in an
emergency setting: a qualitative study of the experiences and views of
women and healthcare professionals. Trials. 2016;17(1):195.
9. Donovan JL, et al. Clear obstacles and hidden challenges: understanding
recruiter perspectives in six pragmatic randomised controlled trials. Trials.
2014;15(1):5.
10. Lawton R, et al. Intervention fidelity and effectiveness of a UK worksite
physical activity intervention funded by the Bupa Foundation, UK. Health
Promot Int. 2015;30(1):38–49.
11. de Salis I, et al. Using qualitative research methods to improve recruitment
to randomized controlled trials: The Quartet study. J Health Serv Res Policy.
2008;13(3_suppl):92–6.
12. Adams M, Caffrey L, McKevitt C. Barriers and opportunities for enhancing
patient recruitment and retention in clinical research: findings from an
interview study in an NHS academic health science centre. Health Res
Policy Sys. 2015;13(1):8.
13. Tooher RL, Middleton PF, Crowther CA. A thematic analysis of factors
influencing recruitment to maternal and perinatal trials. BMC Pregnancy
Childbirth. 2008;8(1):36.
14. Brueton VC, et al. Strategies to improve retention in randomised trials: a
Cochrane systematic review and meta-analysis. BMJ Open. 2014;4(2):e.
003821.
15. Gneezy U, Meier S, Rey-Biel P. When and why incentives (don’t) work to
modify behavior. J Econ Perspect. 2011;25(4):191–210.
16. Bonner SE, Sprinkle GB. The effects of monetary incentives on effort and
task performance: theories, evidence, and a framework for research. Acc
Organ Soc. 2002;27(4):303–45.
17. Bower P, et al. Interventions to improve recruitment and retention in clinical
trials: a survey and workshop to assess current practice and future priorities.
Trials. 2014;15(1):399.
18. Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview
studies: guided by information power. Qual Health Res. 2015;26(13):1753–60.
19. Denzin NK. Lincoln YS. The SAGE handbook of qualitative research.
London: SAGE; 2017.
20. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol.
2006;3(2):77–101.
21. Strauss A, Corbin JM, Basics of qualitative research: techniques and
procedures for developing grounded theory. London: SAGE; 1998.
22. Bazeley P, Jackson K. Qualitative data analysis with NVivo. London: SAGE;
2013.
23. Guest G, Bunce A, Johnson L. How many interviews are enough?: an
experiment with data saturation and variability. Field Methods. 2006;
18(1):59–82.
24. Timmins F. Critical practice in nursing care: analysis, action and reflexivity.
Nurs Stand. 2006;20(39):49–54.
25. Clarke M, et al. The SWAT (study within a trial) programme; embedding
trials to improve the methodological design and conduct of future
research. Trials. 2015;16(2):209.
26. World Bank Group, W.B. World Bank Countries and Income. 2018; Available
from: http://data.worldbank.org/country.
27. Joseph PD, et al. Stakeholder views of clinical trials in low- and middle-
income countries: a systematic review. Pediatrics. 2016;137(2):e20152800.
28. Gikonyo C, et al. Taking social relationships seriously: lessons learned from
the informed consent practices of a vaccine trial on the Kenyan Coast. Soc
Sci Med. 2008;67(5):708–20.
29. Opendenakker R. Advantages and Disadvantages of Four Interview
Techniques in Qualitative Research.Forum Qualitative Sozialforschung /
Forum: Qualitative Social Research, [S.l.], v. 7, n. 4, sep. 2006. ISSN 1438-5627.
Available at: http://www.qualitative-research.net/index.php/fqs/article/view/175.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Daykin et al. Trials  (2018) 19:76 Page 11 of 11
